article thumbnail

Handling HPAPIs safely – what does it take?

European Pharmaceutical Review

” Highly potent APIs are pharmacologically and biologically active compounds at low doses. The compounds require special handling due to their cytotoxicity in the NCEs and investigational new drug applications (INDs). Managing highly potent cytotoxic compounds in early phases and at a late stage is a complex process.

article thumbnail

Connected customer data: a golden opportunity for pharma marketers

pharmaphorum

Approximately 30% of global data volume is generated by the healthcare industry and it will continue to expand with a compound annual growth rate predicted to reach 36% by 2025, according to research by RBC Capital Markets. billion by 2026, according to research by the Business Research Company. billion in 2021 to $9.23

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Top Performing Drug of 2021 - Trulicity (February Edition)

PharmaShots

In the US, Trulicity is protected by a compound patent (2027) and by biologics data protection (2026).

article thumbnail

AI For Talent Acquisition in Tech – Part 3

Fuld

Actions Companies Should Take Today: Learn to use easy AI tools, like email sorting systems and schedulers and ensure that tools are streamlined; Communicate with employee alumni networks to gain a competitive edge with fresh talent.